Citadel Advisors
IH

Citadel Advisors’s iHuman IH Stock Holding History

Citadel Advisors’s Portfolio IH Stock Details IH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45.8K Buy
32,689
+7,661
+31% +$12.3K ﹤0.01% 13161
2026
Q1 		$42.7K Buy
25,028
+4,314
+21% +$8K ﹤0.01% 12461
2025
Q4 		$43.5K Buy
20,714
+4,556
+28% +$12.1K ﹤0.01% 12097
2025
Q3 		$46.7K Sell
16,158
-19,229
-54% -$53.3K ﹤0.01% 12241
2025
Q2 		$88.5K Sell
35,387
-20,107
-36% -$44.8K ﹤0.01% 11422
2025
Q1 		$118K Buy
55,494
+7,811
+16% +$15.6K ﹤0.01% 11236
2024
Q4 		$80.6K Buy
47,683
+9,314
+24% +$16.6K ﹤0.01% 11773
2024
Q3 		$88.2K Sell
38,369
-1,349
-3% -$2.21K ﹤0.01% 11283
2024
Q2 		$71.1K Buy
39,718
+20,745
+109% +$38.4K ﹤0.01% 11359
2024
Q1 		$32.3K Buy
+18,973
New +$44K ﹤0.01% 12627
2023
Q4 		– Sell
-14,510
Closed -$43.8K – 14744
2023
Q3 		$43.8K Buy
14,510
+4,146
+40% +$12.8K ﹤0.01% 11902
2023
Q2 		$30.7K Buy
+10,364
New +$32.1K ﹤0.01% 12332
2021
Q3 		– Sell
-49,923
Closed -$516K – 14198
2021
Q2 		$516K Buy
+49,923
New +$550K ﹤0.01% 10001

Other funds holding IH

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $49.3B AUM 36.45% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citadel Advisors's IH Position: Q2 2026 in Review

Citadel Advisors increased its iHuman (IH) stake by 31% in Q2 2026, buying an estimated $12.3K and bringing the position to 32,689 shares worth $45.8K. The position accounts for ﹤0.01% of the portfolio, ranked #13161.

Citadel Advisors first reported a position in IH in Q2 2021 and has held it in 13 quarters since. The position peaked at $516K in Q2 2021. 8 funds tracked by Wall St. Rank hold IH as of Q2 2026.

  • Citadel Advisors held 32,689 shares of iHuman worth $45.8K as of Q2 2026.
  • Citadel Advisors bought 7,661 iHuman shares in Q2 2026, an estimated $12.3K.
  • iHuman made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13161 holding.
  • Citadel Advisors first reported a position in iHuman in Q2 2021 and has held it in 13 quarters since.
  • Citadel Advisors's iHuman position peaked at $516K in Q2 2021.
  • 8 funds tracked by Wall St. Rank held iHuman as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.